image

The best stocks to buy since 1993

Latest issue now available

Creston

August 2011

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • CRE
  • Price:
  • 85p
A couple of months ago, Creston shares were on fire rising to a high of almost 120p but they seem to have sadly given up the ghost in the last month. Not that there has been anything untoward in the latest full year results nor have brokers changed their expectations, with Investec still forecasting £14.4m pretax and eps of 17.1p for the current year. As it was for the year to 31 March 2011, Creston reported sales up 11% to £67.8m (7% organic growth). Pretax profit was marginally up at £10.4m for eps of 12.3p. Margins in 2011 were 15.9% but this masks a stronger H2 margin of 17.7%, up from 13.9% in H1. But  of course, it was a watershed time with the sale of its advertising business, DLKW and the acquisition of Coon ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMITED PERIOD OFFER!

SUBSCRIBE TODAY AND SAVE £30 WITH OFFER CODE 30OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe